Update on the Therapeutic Drug Monitoring in IBD: Is it Time We Use it in Situations other Than Loss of Response

08/06/2018

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
Bharati Kochar, MD, on Dietary and Microbial Therapy in IBD
06/22/2020
In this video, Bharati Kochar, MD, IBD specialist at the Massachusetts General Hospital in Boston, gives us a preview of her presentation for the Advances in Inflammatory Bowel Disease virtual 2020 regional...
06/22/2020
COVID-19
COVID-19
Christian Sandrock, MD, on How I Practice Now: Increasing Efficiency to Prevent the Spread of Disease
12/21/2020
In this video, Christian Sandrock, MD, discusses the changes that he and his team have made when interacting with patients in-person, and how creating a "lean-and-mean" clinical team can help to prevent the...
12/21/2020
Gastroenterology
video
Gastroenterology
New biologic therapies that target the IL-12/23 Pathway
08/07/2018
08/07/2018
Lipid & Metabolic
Michael J. Bloch, MD
Lipid & Metabolic
CRS 2015: Therapeutic Advances in Hypercholesterolemia: Examining the Role of PCSK-9 Inhibitors in Addressing Unmet Needs
09/28/2015
Faculty Member Michael J. Bloch, MD, talks about PCSK9 with Co-Chair Edward Shahady, MD, FAAFP, ABCL.
09/28/2015
Gastroenterology
B Abraham
Gastroenterology
Bincy Abrahams, MD, on Treating IBD Without the mAbs and the JAKs
09/25/2020
In this 3-minute video, Dr Abraham reviews her discussion of how to treat IBD without biologics, Janus kinase inhibitors, and other new therapeutic agents.
09/25/2020